What are the next steps for a patient experiencing an oculogyric crisis, characterized by upward eye rolling for a few minutes without pain, months after starting Abilify (aripiprazole)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 7, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Oculogyric Crisis Months After Starting Abilify

Immediately administer diphenhydramine 50 mg orally or intramuscularly, or benztropine 1-2 mg IM/IV, which should resolve the upward eye rolling within minutes to one hour, then discontinue or reduce the aripiprazole dose. 1, 2, 3, 4

Immediate Acute Treatment

  • Administer anticholinergic medication as first-line therapy: Give diphenhydramine 25-50 mg IM/IV or benztropine 1-2 mg IM/IV immediately upon recognition of oculogyric crisis. 1, 2, 3

  • Expect rapid symptom resolution: Anticholinergic agents typically reverse acute dystonic reactions including oculogyric crisis within minutes, with complete resolution often occurring within one hour. 2, 4

  • Monitor for laryngeal involvement: Although your patient describes no pain, assess for any choking sensation, difficulty breathing, or stridor, as laryngeal dystonia can accompany oculogyric crisis and represents a life-threatening emergency requiring immediate anticholinergic treatment. 1, 2, 3

Medication Management After Acute Episode

  • Hold or discontinue aripiprazole immediately: The oculogyric crisis indicates an acute dystonic reaction to the medication, and continuing it risks recurrence. 4, 5

  • Consider dose reduction as alternative to discontinuation: If aripiprazole must be continued for psychiatric stability, reduce to the lowest effective dose, as one case report demonstrated successful management of aripiprazole-induced oculogyric crisis with dose reduction alone. 5

  • Continue oral anticholinergic prophylaxis for several days: After initial parenteral treatment, prescribe oral anticholinergics (such as benztropine or diphenhydramine) for a few days to prevent recurrence while the antipsychotic clears from the system. 6

Risk Factors Present in This Case

This patient has multiple high-risk features that explain why oculogyric crisis occurred even with aripiprazole, which typically has lower extrapyramidal side effect rates:

  • Young age is the single most significant risk factor for drug-induced dystonia, with substantially higher risk than in adults. 3, 4

  • Male sex increases susceptibility across all age groups for acute dystonic reactions. 3, 4

  • Delayed onset (months after initiation) is recognized: While acute dystonia typically occurs after the first few doses or dose increases, it can develop after prolonged treatment, as occurred in this case. 1

Alternative Antipsychotic Selection

If antipsychotic treatment remains necessary:

  • Switch to clozapine if other atypicals fail: Two case reports demonstrated that patients with oculogyric crisis on quetiapine and olanzapine who did not respond to anticholinergics were successfully stabilized by switching to clozapine. 5

  • Consider risperidone as alternative: One case successfully switched from amisulpride-induced oculogyric crisis to risperidone with anticholinergic combination. 5

  • Avoid high-potency dopamine D2 antagonists: Haloperidol and typical antipsychotics carry the highest risk for recurrent dystonic reactions. 3

Critical Clinical Pitfalls

  • Do not mistake this for a seizure or functional disorder: Oculogyric crisis maintains intact awareness throughout the episode, distinguishing it from epilepsy, and the sustained upward conjugate gaze differentiates it from tics or functional movement disorders. 6

  • Do not continue the same dose of aripiprazole: Even though aripiprazole has a reported 0% rate of dystonia in some studies, case reports clearly document oculogyric crisis as a rare but real adverse effect requiring intervention. 1, 4, 5

  • Do not assume atypical antipsychotics are completely safe from extrapyramidal symptoms: The notion that atypical antipsychotics carry no dystonia risk is incorrect—they have lower but not zero risk, particularly in young males. 4, 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Oculogyric Crisis in Parkinson's Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Medications That Cause Acute Dystonia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Oculogyric crisis with atypical antipsychotics: A case series.

Indian journal of psychiatry, 2017

Research

[A drug induced deviation of the eyes: the oculogyric crisis].

Nederlands tijdschrift voor geneeskunde, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.